Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cellectis S.A. (CLLS)

« Back to company index

CLLS Chatter Timeline

Stock Ticker for CLLS

Most Active Tweeters for CLLS

UserTweets
@bulletin_en 6
@portefeuillefun 6
@AmericanBanking 4
@dakotafinancial 3
@apppro1 2

Recent Tweets for CLLS

apppro1 @apppro1
@shortsqueeeeze $clls why is getting demolished too???????????
May 23rd 2019, 3:05pm
apppro1 @apppro1
$clls Now the F what
May 23rd 2019, 3:05pm
portefeuillefun @portefeuillefun
Bought 2k $CLLS at $17.03, now 11k #vssporte shares.
May 23rd 2019, 2:05pm
GansStephane @GansStephane
@mchilberg You forget $clls stake in calyxt ????
May 23rd 2019, 12:05pm
WeekHerald @WeekHerald
Cellectis SA $CLLS Receives $35.25 Average Target Price from Analysts https://t.co/PWKuw00lJd
May 23rd 2019, 10:05am
dakotafinancial @dakotafinancial
Cellectis $CLLS versus Amgen $AMGN Head to Head Analysis https://t.co/kJxKC94qyz
May 23rd 2019, 9:05am
dailypoliticaln @dailypoliticaln
Analysts Expect Cellectis SA $CLLS Will Post Earnings of -$0.65 Per Share https://t.co/iO6O7MPbiu
May 22nd 2019, 10:05am
ZolmaxNews @ZolmaxNews
$3.45 Million in Sales Expected for Cellectis SA $CLLS This Quarter https://t.co/aPuC4UTwkh
May 22nd 2019, 10:05am
TrdngDrivatives @TrdngDrivatives
RT @StockNewsWires: $CLLS: Outlook On Cellectis Shows Bullish Short-Term Fading In Long Term: https://t.co/1nibCFmnvn
May 21st 2019, 9:05pm
StockNewsWires @StockNewsWires
$CLLS: Outlook On Cellectis Shows Bullish Short-Term Fading In Long Term: https://t.co/1nibCFmnvn
May 21st 2019, 8:05pm
SeekingAlpha @SeekingAlpha
$CLLS - Outlook On Cellectis Shows Bullish Short-Term Fading In Long Term https://t.co/pgbrKkoOHU
May 21st 2019, 8:05pm
portefeuillefun @portefeuillefun
Sold 500 $CLLS at €16.81, now 9k #vssporte shares.
May 21st 2019, 10:05am
ChartMill @ChartMill
$CLLS has a Current Ratio of 9.77, so it is financially healthy and has no problem in meeting its obligations.… https://t.co/3ouHcW3JH7
May 21st 2019, 6:05am
portefeuillefun @portefeuillefun
Sold 500 $CLLS at €16.93, now 9.5k #vssporte shares.
May 21st 2019, 5:05am
TheMarketsDaily @TheMarketsDaily
Cellectis SA $CLLS Given Average Recommendation of “Hold” by Analysts https://t.co/EF0nZtCATR
May 20th 2019, 2:05am
AmericanBanking @AmericanBanking
Cellectis SA $CLLS Receives Consensus Recommendation of “Hold” from Analysts https://t.co/JDzuPawl9i #stocks
May 20th 2019, 2:05am
AmericanBanking @AmericanBanking
$3.45 Million in Sales Expected for Cellectis SA $CLLS This Quarter https://t.co/ecd7vg6kQl #stocks
May 19th 2019, 8:05am
dakotafinancial @dakotafinancial
Zacks: Analysts Expect Cellectis SA $CLLS Will Announce Quarterly Sales of $3.45 Million https://t.co/5yu9oRk3yj
May 19th 2019, 8:05am
bulletin_en @bulletin_en
BidaskScore Cuts Red Hat $RHT To "Sell"; Cellectis S.A. $CLLS Had 1 Bulls https://t.co/CZkSTLWEaS
May 19th 2019, 6:05am
bulletin_en @bulletin_en
Comparison of TRACON Pharmaceuticals Inc. $CLLS https://t.co/ixgUjKvkRG
May 19th 2019, 4:05am
bulletin_en @bulletin_en
XOMA Corporation $CLLS https://t.co/7ai0Ld8Djg
May 18th 2019, 6:05pm
AmericanBanking @AmericanBanking
Analysts Anticipate Cellectis SA $CLLS to Announce -$0.65 EPS https://t.co/8T5Wc7M5Ob #stocks
May 17th 2019, 8:05am
WeekHerald @WeekHerald
Zacks: Brokerages Expect Cellectis SA $CLLS Will Post Earnings of -$0.65 Per Share https://t.co/Epu3oJARTq
May 17th 2019, 8:05am
FinZTribune @FinZTribune
Reviewing Oncolytics Biotech Inc. $CLLS's results https://t.co/xWUEz9scrl
May 17th 2019, 6:05am
WKRBNews @WKRBNews
Head-To-Head Comparison: Alector $ALEC & Cellectis $CLLS https://t.co/VvetE6sGed #markets
May 17th 2019, 3:05am
portefeuillefun @portefeuillefun
Bought 2k $CLLS at $18.93, now 10k #vssporte shares.
May 16th 2019, 12:05pm
bulletin_en @bulletin_en
Cerus Corporation $CLLS https://t.co/RK2zMHSdIT
May 16th 2019, 8:05am
portefeuillefun @portefeuillefun
Sold 1k $CLLS at €17.07, now 8k #vssporte shares.
May 16th 2019, 3:05am
BehaviorFin @BehaviorFin
@mchilberg @bradloncar Specially as $CLLS sp was +1% yesterday Usually the other way around despite their futures b… https://t.co/XjBrfMNFrz
May 16th 2019, 2:05am
BehaviorFin @BehaviorFin
$ALLO $CLLS https://t.co/qbNDmPWBid
May 16th 2019, 2:05am
dakotafinancial @dakotafinancial
Jefferies Financial Group Comments on Cellectis SA’s FY2021 Earnings $CLLS https://t.co/9XXNhv3bja
May 15th 2019, 4:05am
bulletin_en @bulletin_en
Comparing of Merrimack Pharmaceuticals Inc. $CLLS https://t.co/yYLnhmhF5m
May 14th 2019, 9:05am
ThisLincolnian @ThisLincolnian
Jefferies Financial Group Brokers Reduce Earnings Estimates for Cellectis SA $CLLS https://t.co/0AQEkv734r
May 14th 2019, 4:05am
portefeuillefun @portefeuillefun
$ALLO $CLLS. #Servier Annual Report 2017/2018 https://t.co/fAtezE42yO.
May 13th 2019, 12:05pm
bulletin_en @bulletin_en
Comparison of Verastem Inc. $CLLS https://t.co/NUf1CHaMMK
May 13th 2019, 10:05am
AmericanBanking @AmericanBanking
FY2021 EPS Estimates for Cellectis SA $CLLS Reduced by Analyst https://t.co/1IgM6xH8p8 #stocks
May 13th 2019, 4:05am
dispatchtribune @dispatchtribune
FY2021 EPS Estimates for Cellectis SA $CLLS Reduced by Analyst https://t.co/CFxYfEPbE6
May 13th 2019, 4:05am
operationoxygen @operationoxygen
RT @BertrandBio: Servier UCART19 trials resumed enrollment $CLLS $ALLO https://t.co/xl1gU1QlQb
May 9th 2019, 11:05am
BertrandBio @BertrandBio
Servier UCART19 trials resumed enrollment $CLLS $ALLO https://t.co/xl1gU1QlQb
May 9th 2019, 11:05am
mchilberg @mchilberg
$CLLS update 1Q #Genetherapy https://t.co/Ca6mB4Gb4y
May 8th 2019, 1:05pm
portefeuillefun @portefeuillefun
Bought 1k $CLLS at €17.71, now 9k #vssporte shares.
May 8th 2019, 5:05am
sesiegler @sesiegler
This is very bad news for $ALLO and $CLLS. Anything that could add to neurotoxicity should fail FEMA. Cy flu FTW?… https://t.co/0N35vGUZ48
May 7th 2019, 6:05pm
MarketCurrents @MarketCurrents
$CLLS - Cellectis beats by $0.40, misses on revenue https://t.co/OTjzpjGign
May 7th 2019, 5:05pm
apppro1 @apppro1
$CLLS Cash position1 of $425 million as of March 31, 2019
May 7th 2019, 5:05pm
apppro1 @apppro1
$CLLS Cellectis Reports Financial Results for First Quarter 2019 https://t.co/xg4ZERLifj via @YahooFinance
May 7th 2019, 5:05pm
biotechradar_eu @biotechradar_eu
RT @cellectis: Cellectis announced the company's financial results for Q1 2019. $CLLS
May 7th 2019, 4:05pm
cellectis @cellectis
Cellectis announced the company's financial results for Q1 2019. $CLLS
May 7th 2019, 4:05pm
newswithvalue @newswithvalue
$CLLS: Cellectis Reports Financial Results for First Quarter 2019: https://t.co/C8o2535ihU
May 7th 2019, 4:05pm
BertrandBio @BertrandBio
I guess there's a dose dependency or smthg but alemtuzumab used in $ALLO $CLLS lymphodepletion regimen should perh… https://t.co/S2sf4YRAdZ
May 7th 2019, 2:05pm
WayneKoberstein @WayneKoberstein
RT @JacobPlieth: Nine months on, UCART19 cause of death is still "under investigation". $CLLS slide from this month's #CARTCR $PFE https://…
May 7th 2019, 1:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.